Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea's Pharmaceutical Output Stays Healthy

This article was originally published in PharmAsia News

Executive Summary

SEOUL - The outlook for Korea's pharmaceutical market remains strong with pharmaceutical production rising 9.25 percent in 2008 to KRW13.76 trillion ($12.47 billion) from 2007, Korea FDA reported

You may also be interested in...



Korea Launches Inter-agency Body To Stimulate Local R&D, Earmarks $440 Million For Program

SEOUL - The Korean government has set up an inter-ministry team to support local pharmaceutical companies develop globally competitive drugs. The team will offer R&D training for companies looking to diversify their generic pipelines with innovative products as well as some of the start-up cash needed for new R&D programs

Korea Launches Inter-agency Body To Stimulate Local R&D, Earmarks $440 Million For Program

SEOUL - The Korean government has set up an inter-ministry team to support local pharmaceutical companies develop globally competitive drugs. The team will offer R&D training for companies looking to diversify their generic pipelines with innovative products as well as some of the start-up cash needed for new R&D programs

South Korea Health Ministry Seeks New Drug Reimbursement Pricing System

SEOUL - South Korea's health ministry has assigned a special task force to review the country's drug reimbursement pricing system, which is plagued by high costs for generic drugs and fraud linked to incentive rebates paid to doctors and hospitals

Related Content

UsernamePublicRestriction

Register

SC072962

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel